{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:29:54Z","timestamp":1789504194408,"version":"build-2803163510"},"reference-count":90,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Deanship of Scientific Research, University of Tabuk. Saudi Arabia","award":["S-1440-0333"],"award-info":[{"award-number":["S-1440-0333"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CIMB"],"abstract":"<jats:p>The regulation of apoptosis (the programmed cell death) is dependent on the crucial involvement of BCL2 and BAX. The Bax-248G&gt;A and Bcl-2-938 C&gt;A polymorphic variations in the promoter sequences of the Bax and Bcl-2 gene have been recently associated with low Bax expression, progression to advanced stages, treatment resistance, and shortened overall survival rate in some hematological malignancies, including chronic myeloid leukemia (CML) and other myeloproliferative neoplasms. Chronic inflammation has been linked to various stages of carcinogenesis wherein pro-inflammatory cytokines play diverse roles in influencing cancer microenvironment leading to cell invasion and cancer progression. Cytokines such as TNF-\u03b1 and IL-8 have been implicated in cancer growth in both solid and hematological malignancies with studies showing their elevated levels in patients. Genomic approaches have in recent years provided significant knowledge with the regard to the association of certain SNPs (single nucleotide polymerphisms) either in a gene or its promoter that can influence its expression, with the risk and susceptibility to human diseases including cancer. This study has investigated the consequences of promoter SNPs in apoptosis genes Bax-248G&gt;A (rs4645878)\/Bcl-2-938C&gt;A (rs2279115) and pro-inflammatory cytokines TNF-\u03b1 rs1800629 G&gt;A\/IL-8 rs4073 T&gt;A on the risk and susceptibility towards hematological cancers. The study design has 235 individuals both male and female enrolled as subjects that had 113 cases of MPDs (myeloproliferative disorders) and 122 healthy individuals as controls. The genotyping studies were conducted through ARMS PCR (amplification-refractory mutation system PCR). The Bcl-2-938 C&gt;A polymorphism showed up in 22% of patients in the study, while it was observed in only 10% of normal controls. This difference in genotype and allele frequency between the two groups was significant (p = 0.025). Similarly, the Bax-248G&gt;A polymorphism was detected in 6.48% of the patients and 4.54% of the normal controls, with a significant difference in genotype and allele frequency between the groups (p = 0.048). The results suggest that the Bcl-2-938 C&gt;A variant is linked to an elevated risk of MPDs in the codominant, dominant, and recessive inheritance models. Moreover, the study indicated allele A as risk allele which can significantly increase the risk of MPDs unlike the C allele. In case of Bax gene covariants, these were associated with an increased risk of MPDs in the codominant inheritance model and dominant inheritance model. It was found that the allele A significantly enhanced the risk of MPDs unlike the G allele. The frequencies of IL-8 rs4073 T&gt;A in patients was found to be TT (16.39%), AT (36.88%) and AA (46.72%), compared to controls who were more likely to have frequencies of TT (39.34%), AT (37.70%) and AA (22.95%) as such, respectively. There was a notable overrepresentation of the AA genotype and GG homozygotes among patients compared to controls in TNF-\u03b1 polymorphic variants, with 6.55% of patients having the AA genotype and 84% of patients being GG homozygotes, compared to 1.63% and 69%, respectively in controls. The data from the current study provide partial but important evidence that polymorphisms in apoptotic genes Bcl-2-938C&gt;A and Bax-248G&gt;A and pro-inflammatory cytokines IL-8 rs4073 T&gt;A and TNF-\u03b1 G&gt;A may help predict the clinical outcomes of patients and determine the significance of such polymorphic variations in the risk of myeloproliferative diseases and their role as prognostic markers in disease management using a case-control study approach.<\/jats:p>","DOI":"10.3390\/cimb45050251","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T02:29:14Z","timestamp":1683080954000},"page":"3933-3952","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Molecular Evaluation of the Impact of Polymorphic Variants in Apoptotic (Bcl-2\/Bax) and Proinflammatory Cytokine (TNF-\u03b1\/IL-8) Genes on the Susceptibility and Progression of Myeloproliferative Neoplasms: A Case-Control Biomarker Study"],"prefix":"10.3390","volume":"45","author":[{"given":"Mamdoh S.","family":"Moawadh","sequence":"first","affiliation":[{"name":"Department of Medical Laboratory Technology (FAMS), University of Tabuk, Tabuk 71491, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashid","family":"Mir","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Technology (FAMS), University of Tabuk, Tabuk 71491, Saudi Arabia"},{"name":"Division of Molecular Biology, Prince Fahd Chair for Biomedical Research, University of Tabuk, Tabuk 71491, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8906-198X","authenticated-orcid":false,"given":"Faris J.","family":"Tayeb","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Technology (FAMS), University of Tabuk, Tabuk 71491, Saudi Arabia"},{"name":"Community College, University of Tabuk, Tabuk 71491, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0760-8759","authenticated-orcid":false,"given":"Orooba","family":"Asim","sequence":"additional","affiliation":[{"name":"Division of Molecular Biology, Prince Fahd Chair for Biomedical Research, University of Tabuk, Tabuk 71491, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8059-5571","authenticated-orcid":false,"given":"Mohammad Fahad","family":"Ullah","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Technology (FAMS), University of Tabuk, Tabuk 71491, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","unstructured":"IARC (2021, November 21). Global Cancer Observatory: Cancer Today. Available online: http:\/\/gco.iarc.fr\/today\/home."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molcel.2009.10.011","article-title":"Emerging Role for Members of the Bcl-2 Family in Mitochondrial Morphogenesis","volume":"36","author":"Autret","year":"2009","journal-title":"Mol. Cell"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"107943","DOI":"10.1016\/j.pharmthera.2021.107943","article-title":"The interplay between apoptosis and cellular senescence: Bcl-2 family proteins as targets for cancer therapy","volume":"230","author":"Basu","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrc883","article-title":"The Bcl2 family: Regulators of the cellular life-or-death switch","volume":"2","author":"Cory","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_6","unstructured":"Sodhi, R.K., and Madan, J. (2021). Clinical Perspectives and Targeted Therapies in Apoptosis, Academic Press."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.molcel.2011.10.001","article-title":"A Unified Model of Mammalian BCL-2 Protein Family Interactions at the Mitochondria","volume":"44","author":"Llambi","year":"2011","journal-title":"Mol. Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1038\/emboj.2011.307","article-title":"Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases","volume":"30","author":"Strasser","year":"2011","journal-title":"EMBO J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/35037710","article-title":"The biochemistry of apoptosis","volume":"407","author":"Hengartner","year":"2000","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0145-2126(97)00006-4","article-title":"Bcl-2 and c-myc expression, cell cycle kinetics and apoptosis during the progression of chronic myelogenous leukemia from diagnosis to blastic phase","volume":"21","author":"Handa","year":"1997","journal-title":"Leuk. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1158\/1078-0432.CCR-06-2673","article-title":"The AA Genotype of the Regulatory BCL2 Promoter Polymorphism (\u2212938C>A) Is Associated with a Favorable Outcome in Lymph Node\u2013Negative Invasive Breast Cancer Patients","volume":"13","author":"Bachmann","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/172460080902400402","article-title":"Association of the AA genotype of the Bcl-2 (-938C > A) promoter polymorphism with better survival in ovarian cancer","volume":"24","author":"Heubner","year":"2009","journal-title":"Int. J. Biol. Markers"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.juro.2009.03.081","article-title":"The bcl2 \u2212938CC Genotype Has Poor Prognosis and Lower Survival in Renal Cancer","volume":"182","author":"Hirata","year":"2009","journal-title":"J. Urol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"K\u00fcnkele, A., Grosse-Lordemann, A., Schramm, A., Eggert, A., Schulte, J.H., and Bachmann, H.S. (2013). The BCL2-938 C > A promoter polymorphism is associated with risk group classification in children with acute lymphoblastic leukemia. BMC Cancer, 13.","DOI":"10.1186\/1471-2407-13-452"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.leukres.2009.05.009","article-title":"BCL2 gene polymorphism could predict the treatment outcomes in acute myeloid leukemia patients","volume":"34","author":"Moon","year":"2010","journal-title":"Leuk. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.3171\/2010.12.JNS10478","article-title":"Association of the CC genotype of the regulatory BCL2 promoter polymorphism (\u2212938C>A) with better 2-year survival in patients with glioblastoma multiforme","volume":"114","author":"Bachmann","year":"2011","journal-title":"J. Neurosurg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000342854","article-title":"Effect of the BCL2 Gene Polymorphism on Survival in Advanced-Stage Non-Small Cell Lung Cancer Patients Who Received Chemotherapy","volume":"84","author":"Masago","year":"2013","journal-title":"Oncology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0165-4608(95)00341-X","article-title":"The Bax gene maps to the glioma candidate region at 19q13.3, but is not altered in human gliomas","volume":"88","author":"Chou","year":"1996","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Sahu, S.K., and Choudhuri, T. (2013). Lack of Association between Bax Promoter (-248G>A) Single Nucleotide Polymorphism and Susceptibility towards Cancer: Evidence from a Meta-Analysis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0077534"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s004280050034","article-title":"Protein expression of p53, p21 (WAF1\/CIP1), Bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas","volume":"436","author":"Bukholm","year":"2000","journal-title":"Virchows Arch.-Int. J. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jamcollsurg.2003.08.008","article-title":"Prognostic significance of p53, Bcl-2, and Bax expression in early breast cancer","volume":"198","author":"Linjawi","year":"2004","journal-title":"J. Am. Coll. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Dorjgochoo, T., Xiang, Y.-B., Long, J., Shi, J., Deming, S., Xu, W.-H., Cai, H., Cheng, J., Cai, Q., and Zheng, W. (2013). Association of Genetic Markers in the BCL-2 Family of Apoptosis-Related Genes with Endometrial Cancer Risk in a Chinese Population. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0060915"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1007\/s13277-013-1299-5","article-title":"Association of BCL2-938C>A genetic polymorphism with glioma risk in Chinese Han population","volume":"35","author":"Li","year":"2014","journal-title":"Tumor Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1200\/JCO.2005.02.192","article-title":"Common Polymorphism G(-248)A in the Promoter Region of the bax Gene Results in Significantly Shorter Survival in Patients With Chronic Lymphocytic Leukemia Once Treatment Is Initiated","volume":"23","author":"Starczynski","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zhang, N., Li, X., Tao, K., Jiang, L., Ma, T., Yan, S., Yuan, C., Moran, M.S., Liang, F., and Haffty, B.G. (2011). BCL-2 (-938C > A) polymorphism is associated with breast cancer susceptibility. BMC Med. Genet., 12.","DOI":"10.1186\/1471-2350-12-48"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/aam.aam_56_18","article-title":"Inflammation and cancer","volume":"18","author":"Singh","year":"2019","journal-title":"Ann. Afr. Med."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Lan, T., Chen, L., and Wei, X. (2021). Inflammatory Cytokines in Cancer: Comprehensive Understanding and Clinical Progress in Gene Therapy. Cells, 10.","DOI":"10.3390\/cells10010100"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2337\/db08-0178","article-title":"Proinflammatory cytokines activate the intrinsic apoptotic pathway in beta-cells","volume":"58","author":"Grunnet","year":"2009","journal-title":"Diabetes"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1084\/jem.20181892","article-title":"Cell death\u2013mediated cytokine release and its therapeutic implications","volume":"216","author":"Place","year":"2019","journal-title":"J. Exp. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00125-022-05654-0","article-title":"Proinflammatory cytokines induce rapid, NO-independent apoptosis, ex-pression of chemotactic mediators and interleukin-32 secretion in human pluripotent stem cell-derived beta cells","volume":"65","author":"Dettmer","year":"2022","journal-title":"Diabetologia"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/s41416-019-0617-0","article-title":"Hsp60 and IL-8 axis promotes apoptosis resistance in cancer","volume":"121","author":"Kumar","year":"2019","journal-title":"Br. J. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"149185","DOI":"10.1155\/2014\/149185","article-title":"Chronic Inflammation and Cytokines in the Tumor Microenvironment","volume":"2014","author":"Landskron","year":"2014","journal-title":"J. Immunol. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2050312120965752","DOI":"10.1177\/2050312120965752","article-title":"Inflammatory cytokines in the pathogenesis of cardiovascular disease and cancer","volume":"8","author":"Amin","year":"2020","journal-title":"SAGE Open Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.3389\/fimmu.2019.01818","article-title":"The TNF Paradox in Cancer Progression and Im-munotherapy","volume":"10","author":"Montfort","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.exphem.2016.10.005","article-title":"Tumor necrosis factor \u03b1 in the onset and progression of leukemia","volume":"45","author":"Zhou","year":"2017","journal-title":"Exp. Hematol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Min, L., Chen, D., Qu, L., and Shou, C. (2014). Tumor Necrosis Factor-A Polymorphisms and Colorectal Cancer Risk: A Meta-Analysis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0085187"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000514885","article-title":"Interleukin 8 Elicits Rapid Physiological Changes in Neutrophils That Are Altered by Inflammatory Conditions","volume":"13","author":"Bernhard","year":"2021","journal-title":"J. Innate Immun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"18411","DOI":"10.1038\/srep18411","article-title":"IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia","volume":"5","author":"Kuett","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1182\/blood.V82.8.2517.2517","article-title":"Constitutive Expression of Interleukin-8 and its Re-ceptor in Human Myeloid and Lymphoid Leukemia","volume":"82","author":"Tobler","year":"1993","journal-title":"Blood"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Allegra, A., Musolino, C., Tonacci, A., Pioggia, G., Casciaro, M., and Gangemi, S. (2020). Clinico-Biological Implications of Modified Levels of Cytokines in Chronic Lymphocytic Leukemia: A Possible Therapeutic Role. Cancers, 12.","DOI":"10.3390\/cancers12020524"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"15286","DOI":"10.1038\/s41598-019-51258-x","article-title":"Genomic Prediction of 16 Complex Disease Risks Including Heart Attack, Diabetes, Breast and Prostate Cancer","volume":"9","author":"Lello","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"424","DOI":"10.4172\/0974-8369.1000424","article-title":"Polymorphisms of BCL2 Gene in Acute Lymphoblastic Leukemia Patients in Pa-kistan and Screening of Phytochemicals to Overcome its Expression","volume":"10","author":"Butt","year":"2017","journal-title":"Biol. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s10038-005-0344-7","article-title":"Association of IL8, CXCR2 and TNF-alpha polymorphisms and airway disease","volume":"51","author":"Matheson","year":"2006","journal-title":"J. Hum. Genet."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Schwab, M. (2011). Encyclopedia of Cancer, Springer.","DOI":"10.1007\/978-3-642-16483-5"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41375-022-01736-5","article-title":"Pathogenesis and management of accelerated and blast phases of chronic myeloid leukemia","volume":"37","author":"Senapati","year":"2023","journal-title":"Leukemia"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Popp, H.D., Kohl, V., Naumann, N., Flach, J., Brendel, S., Kleiner, H., Weiss, C., Seifarth, W., Saussele, S., and Hofmann, W.K. (2020). DNA damage and dna damage response in chronic myeloid leukemia. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21041177"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Abdulmawjood, B., Costa, B., Roma-Rodrigues, C., Baptista, P.V., and Fernandes, A.R. (2021). Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222212516"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Provan, D., and Gribben, J. (2010). Molecular Hematology, John Wiley & Sons.","DOI":"10.1002\/9781444318531"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/j.seminhematol.2004.02.011","article-title":"The chronic myeloproliferative disorders: Clonality and clinical heterogeneity","volume":"41","author":"Spivak","year":"2004","journal-title":"Semin. Hematol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12308-008-0003-y","article-title":"Analysis of single nucleotide polymorphisms in the FAS and CTLA-4 genes of pe-ripheral T-cell lymphomas","volume":"1","author":"Bonzheim","year":"2008","journal-title":"J. Hematop."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/JTO.0b013e3181f8a20e","article-title":"Polymorphisms in the Apoptotic Pathway Gene BCL-2 and Survival in Small Cell Lung Cancer","volume":"6","author":"Knoefel","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/ijc.25904","article-title":"Regulatory BCL2 promoter polymorphism (\u2212938C>A) is associated with adverse outcome in patients with prostate carcinoma","volume":"129","author":"Bachmann","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1182\/blood-2008-07-169110","article-title":"Genetic variants in the candidate genes of the apoptosis pathway and susceptibility to chronic myeloid leukemia","volume":"113","author":"Kim","year":"2009","journal-title":"Blood"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1006\/jsre.2002.6473","article-title":"Bax-Induction Gene Therapy of Pancreatic Cancer","volume":"106","author":"Pirocanac","year":"2002","journal-title":"J. Surg. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1200\/JCO.1999.17.5.1364","article-title":"Analysis of the p53\/Bax pathway in colorectal cancer: Low Bax is a negative prognostic factor in patients with resected liver metastases","volume":"17","author":"Sturm","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1309\/JQ2X3RV3L8F9TGYW","article-title":"Role of bax Mutations in Apoptosis in Colorectal Cancers With Microsatellite Instability","volume":"123","author":"Miquel","year":"2005","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1158\/1078-0432.CCR-06-3063","article-title":"Low Expression of Bax Predicts Poor Prognosis in Patients with Locally Advanced Esophageal Cancer Treated with Definitive Chemoradiotherapy","volume":"13","author":"Kang","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_58","first-page":"7097","article-title":"Correlation between Bax gene polymorphisms and esophagus cancer","volume":"16","author":"Sun","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_59","first-page":"599","article-title":"Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer","volume":"20","author":"Porebska","year":"2006","journal-title":"Vivo"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/jjco\/hyn089","article-title":"Low Expression of Bax Predicts Poor Prognosis in Resected Non-small Cell Lung Cancer Patients with Non-squamous Histology","volume":"38","author":"Jeong","year":"2008","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1093\/carcin\/bgm172","article-title":"Single-nucleotide poly-morphisms at the TP53-binding or responsive promoter regions of Bax and Bcl-2 genes and risk of squamous cell carcinoma of the head and neck","volume":"28","author":"Chen","year":"2007","journal-title":"Carcinogenesis"},{"key":"ref_62","first-page":"381","article-title":"Expression of Bcl-2 and Bax in Advanced or Metastatic Prostate Carcinoma","volume":"9","author":"Anvari","year":"2012","journal-title":"Urol. J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4149\/neo_2012_061","article-title":"The clinicopathological significance of Bax and Bcl-2 protein expression with tumor infiltrating lymphocytes in ovarian carcinoma","volume":"59","author":"Yigit","year":"2012","journal-title":"Neoplasma"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/dc.21580","article-title":"The effect of raloxifene on Bax protein expression in breast carcinomas of postmenopausal women","volume":"40","year":"2012","journal-title":"Diagn. Cytopathol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1126\/science.270.5233.96","article-title":"Bax-Deficient Mice with Lymphoid Hyperplasia and Male Germ Cell Death","volume":"270","author":"Knudson","year":"1995","journal-title":"Science"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/385637a0","article-title":"Bax suppresses tumorigenesis and stimulates apoptosis in vivo","volume":"385","author":"Yin","year":"1997","journal-title":"Nature"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/(SICI)1096-9896(199812)186:4<378::AID-PATH203>3.0.CO;2-5","article-title":"Infrequent bax gene mutations in B-cell lymphomas","volume":"186","author":"Peng","year":"1998","journal-title":"J. Pathol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/13685538.2018.1470233","article-title":"Homeostasis: Apoptosis and cell cycle in normal and pathological prostate","volume":"23","author":"Torrealba","year":"2021","journal-title":"Aging Male"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hed.25471","article-title":"Role and regulation of pro-apoptotic Bax in oral squamous cell carcinoma and drug resistance","volume":"41","author":"Alam","year":"2019","journal-title":"Head Neck-J. Sci. Spec. Head Neck"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MD.0000000000011591","article-title":"Prognostic value and susceptibility of Bax rs4645878 polymorphism in cancer A systematic review and meta-analysis","volume":"97","author":"Feng","year":"2018","journal-title":"Medicine"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.21873\/anticanres.15870","article-title":"The Contribution of Interleukin-8 Rs4073 Genotypes to Triple Negative Breast Cancer Risk in Taiwan","volume":"42","author":"Wang","year":"2022","journal-title":"Anticancer Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"0300060520904863","DOI":"10.1177\/0300060520904863","article-title":"Association of interleukin 10 rs1800896 polymorphism with susceptibility to breast cancer: A meta-analysis","volume":"48","author":"Zhu","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"ref_73","first-page":"809","article-title":"IL-10 rs1800896 Polymorphism: A Risk Factor for Adult Acute Lymphoblastic Leukemia","volume":"15","author":"Abdalhabib","year":"2022","journal-title":"Pharm. Pers. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/bcr3436","article-title":"Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells","volume":"15","author":"Singh","year":"2013","journal-title":"Breast Cancer Res. BCR"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1590\/s0004-2803.202000000-16","article-title":"Association of il-8 -251t>a (rs4073) polymorphism with susceptibility to gastric cancer: A systematic review and meta-analysis based on 33 case-control studies","volume":"57","author":"Moghimi","year":"2020","journal-title":"Arq. Gastroenterol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1158\/0008-5472.CAN-11-0156","article-title":"IL-8 signaling plays a critical role in the epitheli-al-mesenchymal transition of human carcinoma cells","volume":"71","author":"Fernando","year":"2011","journal-title":"Cancer Res."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Moreno-Guerrero, S.S., Ram\u00edrez-Pacheco, A., Rocha-Ram\u00edrez, L.M., Hern\u00e1ndez-Pliego, G., Egu\u00eda-Aguilar, P., Escobar-S\u00e1nchez, M.A., Reyes-L\u00f3pez, A., Ju\u00e1rez-Villegas, L.E., and Sienra-Monge, J.J.L. (2021). Association of Genetic Polymorphisms and Serum Levels of IL-6 and IL-8 with the Prognosis in Children with Neuroblastoma. Cancers, 13.","DOI":"10.3390\/cancers13030529"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1073\/pnas.72.9.3666","article-title":"An endotoxin-induced serum factor that causes necrosis of tumors","volume":"72","author":"Carswell","year":"1975","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0092-8674(93)90464-2","article-title":"A novel domain within the 55 kd TNF receptor signals cell death","volume":"74","author":"Tartaglia","year":"1993","journal-title":"Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1158\/0008-5472.CAN-08-1565","article-title":"Low Levels of Tumor Necrosis Factor \u03b1 Increase Tumor Growth by Inducing an Endothelial Phenotype of Monocytes Recruited to the Tumor Site","volume":"69","author":"Li","year":"2009","journal-title":"Cancer Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1158\/2159-8290.CD-17-1178","article-title":"Immunotherapy Resistance by Inflammation-Induced Dedifferentiation","volume":"8","author":"Mehta","year":"2018","journal-title":"Cancer Discov."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1158\/0008-5472.CAN-11-3123","article-title":"Epithelial-mesenchymal transition induced by TNF-\u03b1 requires NF-\u03baB-mediated transcriptional upregulation of Twist1","volume":"72","author":"Li","year":"2012","journal-title":"Cancer Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s12079-019-00508-8","article-title":"TGF-\u03b21 and TNF-\u03b1 synergistically induce epithelial to mesenchymal transition of breast cancer cells by enhancing TAK1 activation","volume":"13","author":"Liao","year":"2019","journal-title":"J. Cell Commun. Signal."},{"key":"ref_84","first-page":"e24835","article-title":"Serum Tumor Necrosis Factor-Alpha Levels in Acute Leukemia and Its Prognostic Significance","volume":"14","author":"Verma","year":"2022","journal-title":"Cureus"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Abdalhabib, E.K., Algarni, A., Saboor, M., Alanazi, F., Ibrahim, I.K., Alfeel, A.H., Alanazi, A.M., Alanazi, A.M., Alruwaili, A.M., and Alanazi, M.H. (2022). Association of TNF-\u03b1 rs1800629 with Adult Acute B-Cell Lymphoblastic Leukemia. Genes, 13.","DOI":"10.3390\/genes13071237"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1002\/cam4.2424","article-title":"Cytokine rs361525, rs1800750, rs1800629, rs1800896, rs1800872, rs1800795, rs1800470, and rs2430561 SNPs in relation with prognostic factors in acute myeloid leukemia","volume":"8","author":"Tripon","year":"2019","journal-title":"Cancer Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00580-017-2600-6","article-title":"Tumor necrosis factor-\u03b1 (TNF-\u03b1) \u2212 308 G\/A and lymphotoxin-\u03b1 (LT-\u03b1) +252 A\/G genetic polymorphisms in Egyptian acute lymphoblastic leukemia","volume":"27","author":"Alkhiary","year":"2018","journal-title":"Comp. Clin. Pathol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e22961","DOI":"10.1002\/jcla.22961","article-title":"Chronic myeloid leukemia blast crisis presented with AML of t(9;22) and t(3;14) mimicking acute lymphocytic leukemia","volume":"33","author":"Liu","year":"2019","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1038\/s41467-021-23097-w","article-title":"Clonal evolution and clinical implications of genetic abnormalities in blastic transfor-mation of chronic myeloid leukaemia","volume":"12","author":"Ochi","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Alarc\u00f3n-Payer, C., S\u00e1nchez Su\u00e1rez, M.D.M., Mart\u00edn Rold\u00e1n, A., Puerta Puerta, J.M., and Jim\u00e9nez Morales, A. (2022). Impact of Genetic Polymorphisms and Biomarkers on the Effectiveness and Toxicity of Treatment of Chronic Myeloid Leukemia and Acute Myeloid Leukemia. J. Pers. Med., 12.","DOI":"10.3390\/jpm12101607"}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/45\/5\/251\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:28:19Z","timestamp":1760124499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/45\/5\/251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,2]]},"references-count":90,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["cimb45050251"],"URL":"https:\/\/doi.org\/10.3390\/cimb45050251","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,2]]}}}